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Clinical Governance
Should Be a Priority
When Care Delivery
Systems Are Disrupted
To the Editor.—In their recent paper,
Rogers et al1 highlighted the increased
costs that occur when a local labora-
tory testing system is disrupted and
outpatient tests are sent to a commer-
cial laboratory. We previously de-
scribed how operational efficiencies
should always be managed by clinical
governance and should represent a
tool for improving clinical effective-
ness.2–4 Here, we present our experi-
ence with the conversion of a
laboratory at an infant-maternity hos-
pital (IMH) according to the hub-
and-spoke model,5 and the impact
on the given service.
Three years ago, the IMH was
incorporated into our health care
system, which already included 3
other hospitals within the urban area
of Milan. The laboratory of one of
them (the ‘‘Luigi Sacco’’ academic
hospital) acted as the hub. From
April 2017, all outpatient tests from
IMH were delivered to the hub,
where 1 core laboratory and 5 spe-
cialized sections processed all re-
quests.3 This decreased the average
cost per test from E2.7 (IMH) to E0.7
(hub). Once complete, the laboratory
reports are digitally signed and pub-
lished in the patient’s electronic
health record (EHR). In 2018,
137 638 outpatient reports were re-
leased by the hub, 88.9% (122 299 of
137 638) published on the EHR with-
in 180 minutes from completion.
Longer publication time was explain-
able by repetition of measurements,
lack of samples for ordered tests, or
contact with the front desk to confirm
the request appropriateness accord-
ing to sex, age, or diagnostic ques-
tion.
To evaluate the quality of the service
offered by the hub to IMH outpatients,
we compared the number of reports
released within 180 minutes after com-
pletion related to the outpatients di-
rectly belonging to the hub blood
collection center (in 2018, 76 930) with
those belonging to the IMH (49 534). A
PDF of the final report was released
within 180 minutes for 90.4% (69 609
of 76 930) of hub outpatients and for
86.7% (42 943 of 49 534) of IMH
outpatients, respectively. Although the
difference was statistically significant
(v2, P,.001), we considered the overall
performance of the offered service quite
good. The analysis of time from the
registration of outpatients and the
check-in of their samples in the recip-
ient laboratory for the same tests
evaluated by Rogers et al,1 that is,
aspartate aminotransferase, C-reactive
protein, erythrocyte sedimentation rate
(ESR), low-density lipoprotein choles-
terol, phosphate, and white blood cell
count (WBC), showed that samples
coming from IMH had a median delay
of 50 minutes (interquartile range,
46–63 minutes) when compared with
hub internal samples, compatible with
the courier transportation schedule not
affecting the samples arriving from the
hub collection center. By considering
the previously published 90th percentile
turnaround times (TATs) of our hub
structure,3 we can conclude that in
about 85% (42 100 of 49 534) of IMH
outpatients, the time from phlebotomy
to result posting in the EHR for WBC
was less than 4.7 hours and for ESR
was less than 5.3 hours, markedly
better that the TATs reported by Rogers
et al.1 Therefore, our organization based
on principles of clinical governance2,3
provides an effective health care system
covering a large urban area in which
the quality standards are overlapping
and does not create a fragmented
patchwork with different levels of
service to end users.
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In Reply.—The care delivery system
described in Milan, Italy, is an out-
standing example of how the conti-
nuity of care in laboratory medicine
provides timely results in a multi-
institutional system. Additionally, the
authors describe decreased cost per
test by close to 75% in the integrated
model when the testing is performed
at a central laboratory.
The economic drivers that impact
our ability to have a hub-and-spoke
model relate to managed-care con-
tracting, which either mandates or
favors routing outpatient tests to
external, large-volume reference labo-
ratories. Costs per test at the com-
mercial laboratories are presumed to
be very low, but the test cost does not
account for the hidden costs of main-
taining the system when the testing
goes outside the hospital system.
Optimization of testing within a
health care system, as described in
Milan, would mandate that the current
economic drivers governing those of
us ‘‘across the pond’’ be fundamen-
tally changed.
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